Follistatin inhibits the function of the oocyte-derived factor BMP-15

Biochemical and Biophysical Research Communications

Volumn 289, Issue 5, 2001, Pages 961-966

  Otsuka, Fumio ^a   Moore, R Kelly ^a   Iemura, Shun ichiro ^b   Ueno, Naoto ^b   Shimasaki, Shunichi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 15; FOLLISTATIN; FOLLITROPIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOASSAY; BIOSENSOR; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; HORMONE ACTION; MITOSIS; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; RAT; SURFACE PLASMON RESONANCE;

EID: 0035930917     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6103     Document Type: Article

References (33)

1. TGF-β signaling in growth control, cancer, and heritable diseases
2. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes
3. A novel growth differentiation factor-9 (GDF-9) related factor is coexpressed with GDF-9 in mouse oocytes during folliculogenesis
4. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis
5. Bone morphogenetic protein-15: Identification of target cells and biological functions
6. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression
7. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function
8. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner
9. Growth differentiation factor-9 is required during early ovarian folliculogenesis
10. Overexpression of mouse follistatin causes reproductive defects in transgenic mice
11. Primary structure of the human follistatin precursor and its genomic organization
12. Follistatin gene expression in the ovary and extragonadal tissues
13. Cyclic changes in follistatin gene expression and translation in the rat ovary during the estrous cycle
14. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle
15. Activin-binding protein from rat ovary is follistatin
16. Follistatin binds to both activin and inhibin through the common beta-subunit
17. Activin-binding protein is present in pituitary
18. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum
19. Follistatin and activin: A potential intrinsic regulatory system within diverse tissues
20. Interaction between activin and follicle-stimulating hormone-suppressing protein and their mechanisms of action on cultured rat granulosa cells
21. Follistatin inhibits activin-induced differentiation of rat follicular granulosa cells in vitro
22. Effects of activin and follicle-stimulating hormone (FSH)-suppressing protein/follistatin on FSH receptors and differentiation of cultured rat granulosa cells
23. Follistatin antagonizes the effects of activin-A on steroidogenesis in human luteinizing granulosa cells
24. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells
25. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects
26. Direct binding of follistatin to a complex of bone morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo
27. Recombinant expression of human follistatin with 315 and 288 amino acids: Chemical and biological comparison with native procine follistatin
28. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary
29. Differential control of activin, inhibin, and follistatin proteins in cultured rat granulosa cells
30. Effect of an activin A on follicle-stimulating hormone (FSH) receptor messenger ribonucleic acid levels and FSH receptor expressions in cultured rat granulosa cells
31. Functional analysis of activins during mammalian development
32. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction
33. Different phenotypes for mice deficient in either activins or activin receptor type II